CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can targeted drugs blinatumomab and venetoclax improve outcomes for childhood leukemia?
⭐️ CURE ⭐️ Recruiting nowThis large trial is testing whether adding the targeted drugs blinatumomab or venetoclax to standard chemotherapy can improve survival and reduce side effects in children with intermediate- or high-risk B-cell acute lymphoblastic leukemia (ALL). The study compares different sched…
Matched conditions: CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: ⭐️ CURE ⭐️
Last updated Jul 25, 2026 00:00 UTC
-
Promising new combo aims to tame childhood leukemia with less chemo
Disease control Recruiting nowThis clinical trial is testing a new combination of drugs for children and teens with a specific type of leukemia called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study uses a targeted drug called olverembatinib along with immune therapy (blinat…
Matched conditions: CHILDHOOD LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC